Optimizing dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-305Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-04-01 / Blood 2002 Apr;99(7):2512-7Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma
/in International Publications, Malignant Lymphoma /von 2002-04-01 / Haematologica 2002 Apr;87(4):400-7Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer
/in International Publications, Ovarian Cancer /von 2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-44[Immunotherapy for esophageal carcinoma]
/in Esophageal Carcinoma, International Publications /von 2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-80Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells
/in HIV/AIDS, International Publications /von 2002-03-01 / J. Virol. 2002 Mar;76(6):3007-14Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2002-03-01 / J. Clin. Endocrinol. Metab. 2002 Mar;87(3):1098-104Mouse and human dendritic cell subtypes
/in Dendritic Cells, International Publications /von 2002-03-01 / Nat. Rev. Immunol. 2002 Mar;2(3):151-61Enhancement of hyperthermia-induced apoptosis by local anesthetics on human histiocytic lymphoma U937 cells
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2002-02-22 / J. Biol. Chem. 2002 May;277(21):18986-93
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de